In this month’s Daily Journal column, Intellectual Property Litigation partner Andrew Ong, and Complex Litigation & Dispute Resolution associates Ariel Rogers and Jessica Huang explore two cases that the Court will be considering in a future term: one involving a question of the proper standard for causation in failure-to-warn claims for prescription products, and the other involving waiver of a right to compel arbitration by engaging in litigation.